Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?
Letter to the Editor
Letter to the Editor
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice. We here highlight and discuss the need to take advantage of the common immune targets to design combined strategies to increase clinical responses.
Recently, clinical evidence has raised BMI as an emerging prognostic factor for immunotherapy, regardless of cancer types. In this article we rewirw current data about correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer
In this paper, a new model describing the human immunodeficiency virus (HIV)-acquired immuno deficiency syndrome (AIDS) epidemic spread is proposed. The improvement with respect to the known models has been driven by recent results obtained from historical data collection and the suggestions given by the World Health Organization: the characteristics of the virus diffusion, mainly by body fluids, imply the trivial fact that wise behaviors of healthy subjects and fast timely recognition of a new positive diagnosis should reduce the spread quite fast.
PURPOSE OF REVIEW:
In the previous publication “Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?” Conticini et al. hypothesized that the surplus of lethality of the novel SARS-CoV-2 in Northern Italy may be at least in part explained by the evidence of highest pollution reported in this area, as both severe COVID-19 and smog exposure are correlated to an innate immune system hyper-activation with subsequent lung inflammation and injury.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma